Archive: Prenatal Aneuploidy Screening

3,480 views · Published 19 October 2017 · 1:02:03 · Indexed 31 October 2026

Channel: UW Video · 2017 · Education

Watch on YouTube

The use of circulating cell-free DNA (cfDNA) for detecting fetal aneuploidy has transformed the landscape of prenatal screening since its introduction in 2011. This method is prevalent in high-risk obstetric populations and is increasingly utilized in the general obstetric population. New approaches are now emerging that incorporate cfDNA analysis into routine prenatal screening protocols. In this talk, Dr. Lockwood describes cfDNA screening technologies with an emphasis on the unique biological and analytical challenges that can affect test interpretation.

After viewing this lecture, participants should be able to:
1. Explain the advantages of cell-free DNA prenatal aneuploidy screening
2. Recognize the challenges associated with detecting fetal aneuploidy from maternal cell-free DNA
3. List common causes of false negative and false positive cfDNA screening results
4. Describe secondary or incidental findings that may arise from cell-free DNA prenatal aneuploidy screening

Tina Lockwood, PhD, DABCC, DABMGG, associate professor, Department of Laboratory Medicine, UW, associate director, Genetics and Solid Tumor Diagnostics Laboratory

10/11/17

https://uw.edu/video
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel